<html>
<head><title>
Prepared and filed by St Ives Financial
</title>
</head>
<body bgcolor="#FFFFFF">
<page>
<p align="center"><font size="2" face="serif"><b>UNITED STATES<br>
</b></font><font size="2" face="serif"><b>SECURITIES AND EXCHANGE COMMISSION<br>
</b></font><font size="2" face="serif"><b>Washington, D.C.  20549</b></font></p>
<p align="center"><font size="2" face="serif"><b>___________</b></font></p>
<p align="center"><font size="2" face="serif"><b>FORM 8-K</b></font></p>
<p align="center"><font size="2" face="serif"><b>CURRENT REPORT</b></font></p>
<p align="center"><font size="2" face="serif"><b>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</b></font></p>
<p align="center"><font size="2" face="serif"><b>January 19, 2006<br>
</b></font><font size="2" face="serif">Date of Report (Date of earliest event reported)</font></p>
<p align="center"><b><font face="serif" size="3">APPLERA CORPORATION<br>
</font></b><font size="2" face="serif">(Exact Name of Registrant as Specified in Its Charter)</font></p>
<table width="100%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr valign="top" bgcolor="#ffffff">
<td align="center"><font size="2" face="serif"><b>        Delaware</b></font></td>
<td align="left" width="2%">&nbsp;</td>
<td width="30%" align="center"><font size="2" face="serif"><b>       1-4389</b></font></td>
<td width="2%" align="left">&nbsp;</td>
<td width="31%" align="center"><font size="2" face="serif"><b>           06-1534213</b></font></td>
</tr>
<tr valign="top" bgcolor="#FFFFFF">
<td align="center"><font size="2" face="serif">            (State or Other Jurisdiction<br>
  of
    Incorporation)</font></td>
<td align="left">&nbsp;</td>
<td align="center"><font size="2" face="serif">    (Commission<br>
  File No.)           </font></td>
<td align="left">&nbsp;</td>
<td align="center"><font size="2" face="serif">             (IRS Employer<br>
  Identification
    No.) </font></td>
</tr>
</table>
<p align="center"><font size="2" face="serif"><b>301 Merritt 7<br>
Norwalk, Connecticut  06851</b><br>
(Address of Principal Executive Offices, Including Zip Code)</font></p>
<p align="center"><font size="2" face="serif"><b>(203) 840-2000</b><br>
(Registrant&#146;s
telephone number, including area code)</font></p>
<p align="center"><font size="2" face="serif"><b>N/A<br></b>(Former name or former address, if changed since last report)<br></font></p>
<p align="left"><font size="2" face="serif">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</font></p>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td align="left" width="4%"><img src="emptybox.gif" width="12" height="12"></td>
<td align="left"><font size="2" face="serif">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></td>
</tr>
<tr valign="top">
<td align="left"><img src="emptybox.gif" width="12" height="12"></td>
<td align="left"><font size="2" face="serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></td>
</tr>
<tr valign="top">
<td align="left"><img src="emptybox.gif" width="12" height="12"></td>
<td align="left"><font size="2" face="serif">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></td>
</tr>
<tr valign="top">
<td align="left"><img src="emptybox.gif" width="12" height="12"></td>
<td align="left"><font size="2" face="serif">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></td>
</tr>
</table>
<p align="center">&nbsp;</p>
<hr noshade align="center" width="100%" size="2">
<div style="page-break-before:always"></div>
<page>
<p align="left"><font size="2" face="serif"><b>Item 1.01.&nbsp;&nbsp;&nbsp;Entry into a Material Definitive Agreement.</b></font></p>
<p align="left"><font size="2" face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<i><u>Grant
        of Restricted Stock Units</u>.  </i>At a meeting of the Management Resources
        Committee (the &#147;MRC&#148;)
of the Board of Directors of Applera Corporation (&#147;Applera&#148;) held
on
January 19, 2006, the MRC approved the grant of 3,600 restricted stock units
(&#147;RSUs&#148;)
relating to shares of Applera Corporation &#150; Applied Biosystems Group Common
Stock (&#147;Applied Biosystems Stock&#148;) to Ugo D. DeBlasi, Vice President
and Controller, and an executive officer, of Applera pursuant to the Applera
Corporation/Applied Biosystems Group Amended and Restated 1999 Stock Incentive
Plan.</font></p>
<p align="left"><font size="2" face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
    RSU represents the right to receive one share of Applied Biosystems Stock
    at the time the RSU vests. The RSUs generally vest in four increments of
    up to 25% of the total amount following the end of fiscal years 2006, 2007,
    2008, and 2009, based on the attainment of revenue objectives for the Applied
    Biosystems Group established by the MRC for each of these fiscal years. Any
    RSUs as to which the vesting targets have not been attained will be forfeited.
    RSUs that have not vested will be forfeited and revert back to Applera upon
    termination of employment with Applera or a subsidiary for any reason,
    although the
    MRC has the discretion to modify the vesting requirements based on individual
    circumstances.
Prior to the vesting of the RSUs, the recipient will not be deemed to be the
holder of, or have any of the rights of a holder with respect to, any shares
of Applied Biosystems Stock deliverable with respect to the RSUs.</font></p>
<p align="left"><font size="2" face="serif"><b>Item 2.02.&nbsp;&nbsp;&nbsp;Results of Operations and Financial Condition.</b></font></p>
<p align="left"><font size="2" face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
    January 25, 2006, Applera announced financial results for Applera and its
    business units for the second quarter of its 2006 fiscal year. Attached hereto
    as Exhibit 99.1 and incorporated by reference herein is the text of a press
    release issued on January 25, 2006, with respect to financial results for
    the second quarter of fiscal year 2006 of Applera and Applera&#146;s Applied Biosystems Group, and attached hereto as Exhibit 99.2 and incorporated by reference herein is the text of a press release issued on January 25, 2006, with respect to financial results for the second quarter of fiscal year 2006 of Applera and Applera&#146;s Celera
Genomics Group.  </font></p>
<p align="left"><font size="2" face="serif"><b>Item 9.01.&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits.</b></font></p>
<p align="left"><font size="2" face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><i>(c) Exhibits.</i></b></font></p>
<p align="left"><font size="2" face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following exhibits are filed with this Report:</font></p>
<table width="100%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr valign="top" bgcolor="#FFFFFF">
<td width="9%" align="left"><font size="2" face="serif"><i><u>Exhibit No.</u></i></font></td>
<td align="left"><font size="2" face="serif"><i><u>Description</u></i></font></td>
</tr>
<tr valign="top">
<td align="left"><font size="2" face="serif">&nbsp;</font></td>
<td align="left"><font size="2" face="serif">&nbsp;</font></td>
</tr>
<tr valign="top" bgcolor="#ffffff">
<td align="center"><font size="2" face="serif">99.1</font></td>
<td align="left"><font size="2" face="serif">Press Release issued January 25, 2006, with respect to financial results for Applera and Applera&#146;s Applied Biosystems Group.</font></td>
</tr>
<tr valign="top">
<td align="left"><font size="2" face="serif">&nbsp;</font></td>
<td align="left"><font size="2" face="serif">&nbsp;</font></td>
</tr>
<tr valign="top" bgcolor="#FFFFFF">
<td align="center"><font size="2" face="serif">99.2</font></td>
<td align="left"><font size="2" face="serif">Press Release issued January 25, 2006, with respect to financial results for Applera and Applera&#146;s Celera Genomics Group.</font></td>
</tr>
</table>
<p align="center">&nbsp;</p>
<hr noshade align="center" width="100%" size="2">
<div style="page-break-before:always"></div>
<page>
<p align="center"><font size="2" face="serif"><b>SIGNATURES</b></font></p>
<p align="left"><font size="2" face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></p>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
  <td align="left">&nbsp;</td>
  <td colspan="2" align="left"><font size="2" face="serif"><b>APPLERA CORPORATION</b></font></td>
  </tr>
<tr valign="top">
  <td align="left">&nbsp;</td>
  <td colspan="2" align="left">&nbsp;</td>
</tr>
<tr valign="top">
  <td align="left">&nbsp;</td>
  <td colspan="2" align="left">&nbsp;</td>
  </tr>
<tr valign="top">
  <td align="left" width="50%">&nbsp;</td>
<td align="left" width="3%"><font size="2" face="serif">By: </font></td>
<td align="left"><font size="2" face="serif">/s/ Dennis L. Winger</font></td>
</tr>
<tr valign="top">
  <td></td>
<td></td>
<td><hr noshade size="1"></td>
</tr>
<tr valign="top">
  <td align="left">&nbsp;</td>
<td align="left"><font size="2" face="serif">&nbsp;</font></td>
<td align="left"><font size="2" face="serif">Dennis L. Winger</font></td>
</tr>
<tr valign="top">
  <td align="left">&nbsp;</td>
<td align="left"><font size="2" face="serif">&nbsp;</font></td>
<td align="left"><font size="2" face="serif">Senior Vice President and</font></td>
</tr>
<tr valign="top">
  <td align="left">&nbsp;</td>
<td align="left"><font size="2" face="serif">&nbsp;</font></td>
<td align="left"><font size="2" face="serif">Chief Financial Officer</font></td>
</tr>
<tr valign="top">
  <td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td> </tr>
</table>
<p align="left"><font size="2" face="serif">Dated: January 25, 2006</font></p>
<p align="center">&nbsp;</p>
<hr noshade align="center" width="100%" size="2">
<div style="page-break-before:always"></div>
<page>
<p align="center"><font size="2" face="serif"><b>EXHIBIT INDEX</b></font></p>
<table width="100%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr valign="top" bgcolor="#FFFFFF">
<td width="9%" align="left"><font size="2" face="serif"><i><u>Exhibit No.</u></i></font></td>
<td align="left"><font size="2" face="serif"><i><u>Description</u></i></font></td>
</tr>
<tr valign="top">
<td align="left"><font size="2" face="serif">&nbsp;</font></td>
<td align="left"><font size="2" face="serif">&nbsp;</font></td>
</tr>
<tr valign="top" bgcolor="#ffffff">
<td align="center"><font size="2" face="serif">99.1</font></td>
<td align="left"><font size="2" face="serif">Press Release issued January 25, 2006, with respect to financial results for Applera and Applera&#146;s Applied Biosystems Group.</font></td>
</tr>
<tr valign="top">
<td align="center"><font size="2" face="serif">&nbsp;</font></td>
<td align="left"><font size="2" face="serif">&nbsp;</font></td>
</tr>
<tr valign="top" bgcolor="#FFFFFF">
<td align="center"><font size="2" face="serif">99.2</font></td>
<td align="left"><font size="2" face="serif">Press Release issued January 25, 2006, with respect to financial results for Applera and Applera&#146;s Celera Genomics Group.</font></td>
</tr>
</table>
<p align="center">&nbsp;</p>
<hr noshade align="center" width="100%" size="2">

</body>
</html>
[{"type": "8-K", "sequence": "1", "filename": "b411233_8k.htm", "description": "CURRENT REPORT", "secsgml_size_bytes": 11694}]
{"company-data": {"conformed-name": "APPLERA CORP", "cik": "0000077551", "assigned-sic": "3826", "irs-number": "061534213", "state-of-incorporation": "DE", "fiscal-year-end": "0630"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-04389", "film-number": "06548114"}, "business-address": {"street1": "301 MERRITT 7", "city": "NORWALK", "state": "CT", "zip": "06851", "phone": "2038402000"}, "mail-address": {"street1": "301 MERRITT 7", "city": "NORWALK", "state": "CT", "zip": "06851"}, "former-company": [{"former-conformed-name": "PE CORP", "date-changed": "19990129"}, {"former-conformed-name": "PERKIN ELMER CORP", "date-changed": "19930601"}]}
Prepared and filed by St Ives Financial
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
___________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
January 19, 2006
Date of Report (Date of earliest event reported)
APPLERA CORPORATION
(Exact Name of Registrant as Specified in Its Charter)
Delaware
1-4389
06-1534213
(State or Other Jurisdiction
of
    Incorporation)
(Commission
File No.)
(IRS Employer
Identification
    No.)
301 Merritt 7
Norwalk, Connecticut  06851
(Address of Principal Executive Offices, Including Zip Code)
(203) 840-2000
(Registrant's
telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01.   Entry into a Material Definitive Agreement.
Grant
        of Restricted Stock Units
.
At a meeting of the Management Resources
        Committee (the "MRC")
of the Board of Directors of Applera Corporation ("Applera") held
on
January 19, 2006, the MRC approved the grant of 3,600 restricted stock units
("RSUs")
relating to shares of Applera Corporation – Applied Biosystems Group Common
Stock ("Applied Biosystems Stock") to Ugo D. DeBlasi, Vice President
and Controller, and an executive officer, of Applera pursuant to the Applera
Corporation/Applied Biosystems Group Amended and Restated 1999 Stock Incentive
Plan.
Each
    RSU represents the right to receive one share of Applied Biosystems Stock
    at the time the RSU vests. The RSUs generally vest in four increments of
    up to 25% of the total amount following the end of fiscal years 2006, 2007,
    2008, and 2009, based on the attainment of revenue objectives for the Applied
    Biosystems Group established by the MRC for each of these fiscal years. Any
    RSUs as to which the vesting targets have not been attained will be forfeited.
    RSUs that have not vested will be forfeited and revert back to Applera upon
    termination of employment with Applera or a subsidiary for any reason,
    although the
    MRC has the discretion to modify the vesting requirements based on individual
    circumstances.
Prior to the vesting of the RSUs, the recipient will not be deemed to be the
holder of, or have any of the rights of a holder with respect to, any shares
of Applied Biosystems Stock deliverable with respect to the RSUs.
Item 2.02.   Results of Operations and Financial Condition.
On
    January 25, 2006, Applera announced financial results for Applera and its
    business units for the second quarter of its 2006 fiscal year. Attached hereto
    as Exhibit 99.1 and incorporated by reference herein is the text of a press
    release issued on January 25, 2006, with respect to financial results for
    the second quarter of fiscal year 2006 of Applera and Applera's Applied Biosystems Group, and attached hereto as Exhibit 99.2 and incorporated by reference herein is the text of a press release issued on January 25, 2006, with respect to financial results for the second quarter of fiscal year 2006 of Applera and Applera's Celera
Genomics Group.
Item 9.01.   Financial Statements and Exhibits.
(c) Exhibits.
The following exhibits are filed with this Report:
Exhibit No.
Description
99.1
Press Release issued January 25, 2006, with respect to financial results for Applera and Applera's Applied Biosystems Group.
99.2
Press Release issued January 25, 2006, with respect to financial results for Applera and Applera's Celera Genomics Group.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
APPLERA CORPORATION
By:
/s/ Dennis L. Winger
Dennis L. Winger
Senior Vice President and
Chief Financial Officer
Dated: January 25, 2006
EXHIBIT INDEX
Exhibit No.
Description
99.1
Press Release issued January 25, 2006, with respect to financial results for Applera and Applera's Applied Biosystems Group.
99.2
Press Release issued January 25, 2006, with respect to financial results for Applera and Applera's Celera Genomics Group.